iRhythm Technologies (IRTC) Competitors $136.77 -0.34 (-0.25%) Closing price 07/29/2025 04:00 PM EasternExtended Trading$136.77 0.00 (0.00%) As of 04:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. SNN, SOLV, PEN, STVN, GKOS, BLCO, SLNO, INSP, TMDX, and NVSTShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), TransMedics Group (TMDX), and Envista (NVST). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Its Competitors Smith & Nephew SNATS Solventum Penumbra Stevanato Group Glaukos Bausch + Lomb Soleno Therapeutics Inspire Medical Systems TransMedics Group Envista Smith & Nephew SNATS (NYSE:SNN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations. Do insiders & institutionals believe in SNN or IRTC? 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor SNN or IRTC? In the previous week, Smith & Nephew SNATS had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 6 mentions for Smith & Nephew SNATS and 5 mentions for iRhythm Technologies. Smith & Nephew SNATS's average media sentiment score of 0.99 beat iRhythm Technologies' score of 0.71 indicating that Smith & Nephew SNATS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SNN or IRTC more profitable? Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -15.90%. Smith & Nephew SNATS's return on equity of 0.00% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew SNATSN/A N/A N/A iRhythm Technologies -15.90%-101.04%-9.55% Which has higher valuation & earnings, SNN or IRTC? Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew SNATS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew SNATS$5.81B2.38$412M$2.1614.62iRhythm Technologies$591.84M7.38-$113.29M-$3.14-43.56 Which has more risk and volatility, SNN or IRTC? Smith & Nephew SNATS has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Do analysts recommend SNN or IRTC? Smith & Nephew SNATS presently has a consensus price target of $28.00, indicating a potential downside of 11.35%. iRhythm Technologies has a consensus price target of $137.30, indicating a potential upside of 0.39%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 SummarySmith & Nephew SNATS beats iRhythm Technologies on 11 of the 16 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.38B$2.16B$5.70B$9.55BDividend YieldN/AN/A4.71%4.03%P/E Ratio-43.5637.3528.2019.95Price / Sales7.3829.73390.5767.75Price / CashN/A56.0636.3258.72Price / Book47.169.128.275.77Net Income-$113.29M-$63.64M$3.25B$259.21M7 Day Performance1.59%-5.10%-2.00%-2.40%1 Month Performance-11.17%7.82%8.68%9.41%1 Year Performance53.50%5.35%34.66%16.67% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.0189 of 5 stars$136.77-0.2%$137.30+0.4%+54.4%$4.38B$591.84M-43.562,000Upcoming EarningsSNNSmith & Nephew SNATS2.6175 of 5 stars$30.26+0.3%$28.00-7.5%+9.8%$13.21B$5.81B0.0017,349Positive NewsUpcoming EarningsSOLVSolventum0.8843 of 5 stars$72.37-1.2%$84.38+16.6%+28.3%$12.68B$8.25B13.4222,000Positive NewsPENPenumbra4.5769 of 5 stars$228.19-0.9%$305.07+33.7%+27.5%$8.92B$1.19B215.284,500News CoveragePositive NewsEarnings ReportSTVNStevanato GroupN/A€24.35-2.2%N/A+30.8%€7.37B€1.19B47.755,521GKOSGlaukos4.3967 of 5 stars$96.97-0.7%$134.67+38.9%-21.5%$5.58B$383.48M-40.92780Positive NewsBLCOBausch + Lomb2.0444 of 5 stars$13.92+0.1%$15.45+11.0%-12.3%$4.92B$4.79B28.9613,500News CoverageEarnings ReportSLNOSoleno Therapeutics4.3464 of 5 stars$86.97-0.3%$108.70+25.0%+79.4%$4.39BN/A-18.8230Positive NewsUpcoming EarningsINSPInspire Medical Systems4.8655 of 5 stars$125.13-1.3%$210.27+68.0%-2.8%$3.74B$802.80M57.661,246Positive NewsUpcoming EarningsTMDXTransMedics Group1.9115 of 5 stars$103.61-5.7%$129.88+25.3%-24.6%$3.72B$441.54M76.18210NVSTEnvista2.6007 of 5 stars$19.47-0.2%$20.23+3.9%+23.8%$3.31B$2.51B-2.9812,300Upcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies Smith & Nephew SNATS Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives Inspire Medical Systems Alternatives TransMedics Group Alternatives Envista Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredSmall Cap- AI Hospitals = Big OpportunityA tiny NASDAQ firm just launched a generative AI platform aimed at disrupting a $2 trillion healthcare market....Smallcaps Daily | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thNew China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
